Advertisement

Topics

Avista Pharma Solutions Doubles API Manufacturing Capacity at Colorado Facility

06:00 EST 13 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Facility and Equipment Upgrades Support Processing of Potent Compounds Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capa...

Other Sources for this Article

BAERING
Jordan Watkins, 919-233-6600
jwatkins@baeringgroup.com

NEXT ARTICLE

More From BioPortfolio on "Avista Pharma Solutions Doubles API Manufacturing Capacity at Colorado Facility"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...